Biovision

FAQ


What is the Biovision the World Life Sciences Forum?

It is a unique annual event dedicated to linking life sciences with media, society and industry. Major players from the health sector representing each step of the value chain (research, innovation, partnerships and finance), participate to network, exchange, share, discuss, with the goal of arriving at concrete solutions for existing and future health issues.


Of what is constituted Biovision Forum?

The three main interlinking components of Biovision are Prospective, Catalyzer and Investor. Also, Biovision is working with BIO One-on-One Partnering™ to offer you the best partnering tool. Check out the Networking page for more info.


What is Biovision Prospective?

It is a meeting place for stakeholders in global health to discuss and network. This year’s topic in ‘From Global health to One health’. One health is "the collaborative effort of multiple disciplines - working locally, nationally, and globally - to attain optimal health for people, animals and the environment"
Biovision Prospective will be divided in 6 paths:

where an exchange time, bridge meetings between 20 experts and challengers selected amongst attendees, insights and a delivery of the call for action will take place.


What is Biovision Catalyzer?

It is a springboard for innovative health projects and start-ups in the fields of Biotech, Medtech and e-Health.
Catalyzer will allow selected innovative life sciences Projects and seed stage Startups to connect with potential partners and pitch in front of a prestigious selection committee.


What is Biovision Investor?

Is the intersection of Biotech, Medtech and e-Health start-ups and venture capital.
Investor is dedicated to life sciences startups seeking series A or series B funds within 18 months. The international selection committee gathers more than 15 partners from leading European Venture funds.


Who can participate in Biovision?

Biovision is open to all life sciences stakeholders.


Why should I participate in Biovision 2017?

If you are interested in connecting with your industry peers, in an environment conducive to networking where international Life Sciences stakeholders from academic, policy-making, private and the civil society sectors interact to translate innovative ideas into actionable solutions for the benefit of citizens, then you should participate in this event.


How to sign up for the event?

Signing up for the event is simple. You just click on the registration button at the top right of this website and follow the steps that will guide you through a successful registration


How can I become a sponsor of this forum?

If you are interested in sponsorship opportunities please contact the Director Christophe Dercamp at christophe.dercamp@biovision.org


What are the costs associated with the participation in this event?

Prospective
The early bird prices (20% VAT included) available till 31 January 2017 are:

From February to the 6th of April the prices are: Catalyzer and Investor
No fees are required to submit your application. Fees will only be applicable to the applicants who are selected and confirm their participation for the Biovision Forum 4-6 April 2017.
Once you are chosen to participate, the registration fees are: This allows you to participate in the Catalyzer/Investor pitches, the Prospective sessions and make use of the networking tools (BIO One-on-One Partnering™, Coffee With sessions etc.).
Accommodations and transportation are not included in the fees.


Are there any special rates for hotels or flights?

HOTELS
Biovision has negotiated special rates at the Ibis Hotel Lyon Caluire Cité Internationale.
Individual room 110 € (breakfast Buffet included)
Add 9.90 € for a second person.

To make a reservation email h5234@accor.com and give the code « BIOVISION », or call +33 4 72 27 75 00.
Daily tax not included (1.10 €/day/person)

FLIGHTS
Biovision and Air France have partnered up, in order to bring you the lowest prices. Simply go to www.airfranceklm-globalmeetings.com/?eid=29909AF to get our negotiated prices.